This annual three day event will explore new research into TB detection, treatment and vaccination as well as new developments in controlling and preventing Mycobacterium tuberculosis Infection.
With an informal academic atmosphere and international speakers, it is the perfect environment for debate and discussion.
Deadlines
The Deadline for abstract submissions for oral presentation is 10th March 2016
The early registration deadline is 20th April 2016
The Deadline for abstract submissions for poster presentation is 5th June 2016
Who Should Attend: This event welcomes those working within tuberculosis research and treatment, drug discovery, global health, physicians and those working on novel technologies related to TB detection and control.
The 2016 TB Summit has an open abstract session: Abstracts can be submitted on any subject related to Mycobacterium Tuberculosis
Talks Include
Talk Title | Speaker | Affiliation | Country |
---|---|---|---|
Communicating risks and benefits of preventive tuberculosis treatment for shared decision making | Dr. Claudia Dobler | University of New South Wales | Australia |
On the identifiability of transmission dynamic models for infectious diseases | Dr. Jarno Lintusaari | Aalto University | Finland |
Integrated interdisciplinary approaches to tackle extensively drug resistance in TB | Dr Sanjib Bhakta | University of London | United Kingdom |
TB in healthcare workers | Professor Albert Nienhaus | University Medical Center Hamburg-Eppendorf | Germany |
Host defence mechanisms during early stages of tuberculosis in zebrafish | Professor Annemarie H. Meijer | Leiden University | Netherlands |
Intracellular growth of Mycobacterium tuberculosis; linking microbial physiology to drug development. | Dr. Yossef Av-Gay | The University of British Columbia | Canada |
Understanding and intervening in HIV-tuberculosis | Dr. Robert J Wilkinson | University of Cape Town | South Africa |
Tuberculosis therapeutics that inhibit bacterial sensing and resistance to host immunity | Dr. Rob Abramovitch | Michigan State University | United States |
Pathway for synthesis of methylglucose lipopolysaccharides in Mycobacterium tuberculosis | Dr. Nuno Empadinhas | University of Coimbra | Portugal |
A vaccine pipeline - phage display for biomarker identification and generation of human antibodies for diagnostics and therapy | Dr. Michael Hust | Universität Braunschweig | Germany |
TBC | Dr Amador Goodridge | INDICASAT-AIP | Panama |
Coughing and the transmission of tuberculosis | Dr. Richard Turner | University Hospital NHS Foundation Trust | United Kingdom |
Extensive Drug Resistant Tuberculosis plus Linezolid Resistance: Linezolid resistance development in Lisbon, Portugal | Isabel Portugal | University of Lisbon | Portugal |
TB persisters - resistance is futile, time to end them all | Dr. Yanmin Hu | St George's University of London | United Kingdom |
Development of Dinitrobenzyl Oxadiazoles and Thiadiazoles as Selective Antitubercular Agents | Dr Jaroslav Roh | Charles University in Prague | Czech Republic |
Design and synthesis of antitubercular small molecules targeting drug-resistant mycobacteria | Dr. Daniele Castagnolo | King's College London | United Kingdom |
Development and deployment of new TB drugs | Dr. Gerry Davies | Liverpool, Liverpool | United Kingdom |
TBC | Dr. Frédéric J. Veyrier | INRS-Institut Armand-Frappier | Canada |
Recent Developments in Childhood Tuberculosis | Dr. James A Seddon | Imperial College London | United Kingdom |
Adjunctive immunotherapy of tuberculosis using vitamin D and phenylbutyrate: a randomized double-blind clinical trial | Dr. Susanna Brighenti | Karolinska Institutet | Sweden |
TBC | Professor Luis E. Cuevas | School of Tropical Medicine | United Kingdom |
Assessment of terbium (III) as a probe for the detection of tuberculosis biomarkers | Dr. Thu-Hoa Tran-Thi | Centre national de la recherche scientifique | France |
Capturing Geographic Complexity in a Homeless “Neighborhood”: spatial video geonarratives (SVG) in Skid Row, Los Angeles | Professor Andrew Curtis | Kent State University | United States |
Understanding TB transmission with whole-genome sequencing and modelling | Dr. Caroline Colijn | Imperial College London | United Kingdom |
Improvements in Energetics-Based Methods for Target Identification in TB Drug Discovery | Dr. Cristiano V. Bizarro | Pontifícia Universidade Católica do Rio Grande do Sul - PUCRS | Brazil |
The Mtb Divisome: Initial Structural Efforts on Drug Targets | Dr. Timothy A. Cross | Florida State University | United States |
TBC | Professor Onn Min Kon | Imperial College Healthcare NHS Trust | United Kingdom |
Plant natural products for TB treatment and prophylaxis | Dr. R. S. Santhosh | SASTRA University | India |
Rapid differentiation of Mycobacteria | Dr Linda Stewart | Queen's University | United Kingdom |
TBC | Professor Dirk Schnappinger | Weill Cornell Medical College | United States |
TB or not TB? - Metabolomics may hold the answer | Professor Du Toit Loots | North-West University | South Africa |
TBC | Di Zhu | University of Groningen | Netherlands |
TaqMan Array Card for genotypic drug resistance testing | Professor Eric R. Houpt | University of Virginia | United States |
TBC | Dr Dimitrios Evangelopoulos | University College London | United Kingdom |
The role of human gamma/delta T cells in the immunity against the infection of Mycobacterium tuberculosis. | Dr. Baiqing Li | Bengbu Medical College | China |
TBC | Dr Jana Fried | Coventry University | United Kingdom |
PURE-TB-LAMP: Simple & Rapid screenging test for TB | Dr Yasuyoshi Mori, Eike | Chemical Co.,Ltd | Japan |
Genomes, structural biology and drug discovery: Understanding antimicrobial resistance in tuberculosis | Professor Tom Blundell | University of Cambridge | United Kingdom |
TBC | Dr. Ill Young Lee | Korea Research Institute of Chemical Technology | South Korea |
Plants a source of antitubercular agents | Dr. Maria del Rayo Camacho-Corona | Universidad Autónoma de Nuevo León | Mexico |
Transcriptional Regulation in Mycobacteria | Dr. Eric Galburt, Washington | University School of Medicine | United States |
Innate immune recognition of pathogenic mycobacteria | Dr. Antje Blumenthal | The University of Queensland Diamantina Institute | Australia |
Toxin:antitoxin modules as regulators of TB growth and persistence | Associate Professor Shaleen Korch | Midwestern University | United States |
TBC | Dr. Galina Mukamolova | niversity of Leicester | United Kingdom |
Purinergic signaling in the immune response to severe tuberculosis | Professor Maria Regina D'Imperio Lima | Universidade de São Paulo | Brazil |
IFITM family members restrict Mycobacterium tuberculosis infection | Dr Shahin Ranjbar | Harvard Medical School | United States |
TBC | Dr Prakash Udhawdas Tahiliani | Prime Ever Ayurvedic Research Laboratories | India |
Multiple Biomarkers for Reliable Identification of Mycobacterium Tuberculosis Complex in Broth Culture Media with Nanodiamond | Professor Peng Wen-Ping | National Dong Hwa University | Taiwan |
Design of a new short course multt-drug treatment regimen for infants and toddlers that works regardless of type of drug resistance | Dr. Tawanda Gumbo | Baylor Research Institute, Baylor University Medical Center | United States |
De novo design of short synthetic membrane-targeting anti-mycobacterial peptides. | Jasmeet Singh Khara | Imperial College London | United Kingdom |
Advisory Board Members
Member | Affiliation | Country |
---|---|---|
Dr Tomoshige Matsumoto | Osaka Anti-Tuberculosis Association | Japan |
Professor Edith Sim | University of Oxford | United Kingdom |
Mr Michel Baltas | CNRS | France |
Dr Sandrine Lesellier | Animal and Plant Health Agency (APHA) | United Kingdom |
Professor P K Das | University of Amsterdam | The Netherlands |
CPD Credits
Credits from The Institute of Biomedical Science (code) | Approved by the Royal Society of Biology for purposes of CPD | ||
---|---|---|---|
18(MD026N16) | This event may be counted as 54 CPD credits |
Related Past Agendas
Mycobacterium Tuberculosis Infection Treatment – 26th March 2014
Mycobacterium Tuberculosis Infection Detection – 25th March 2014
Mycobacterium Tuberculosis Infection Prevention – 24th March 2014 Forensic Investigations to locate and identify the missing – 5th March 2014
Contact
Phone: (+44) 020 7183 82 31
Registration Fee
Registration includes entry to all the event, lunch and all refreshments, networking opportunities and access to exhibitions.
|
REGISTRATION FEE |
LATE REGISTRATION FEE |
Standard |
£534 (£445 + VAT) |
£654 (£545 + VAT) |
Academic |
£354 (£295 + VAT) |
£474 (£395 + VAT) |
Student |
£234 (£195 + VAT) |
£354 (£295 + VAT) |
If you do not want to attend the full three days you can also book single days at the following price
|
REGISTRATION FEE |
LATE REGISTRATION FEE |
Standard |
£234 (£195 + VAT) |
£330 (£275 + VAT) |
Academic |
£150 (£125 + VAT) |
£234 (£195 + VAT) |
Student |
£114 (£95 + VAT) |
£174 (£145 + VAT) |
Please note: As our services are held in the UK we are obliged to charge VAT even if you are coming from outside the UK
Discounted Group Bookings
If 3 or more people register together, then you will receive a discount of £20.00 off for each person in the group
These discounts are applied automatically on registration
Bursary applications
Euroscicon will consider all applications for bursaries to cover registration, food and refreshments on the day of an event, however these are limited. We cannot, at this time award money for travel or accommodation. To download an application form see www.euroscicon.com/Bursary.docx
Venue, Accommodation and Travel Details
This event will be held at Cineworld: The O2 Peninsula Square London SE10 0DX United Kingdom
Once inside the O2 building please make your way to Cineworld. A map of the O2 can be found by clicking here
For more detailed travel information click here
For accommodation suggestions click here
Map
Abstract and Poster Presentations
All abstracts accepted for oral presentation are also automatically accepted for poster presentation
INSTRUCTIONS
- How to submit your abstract -www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf
- Accepted poster instructions - www.lifescienceevents.com/poster-sessions
- Accepted oral presentation instructions - www.lifescienceevents.com/oral-presentations
Payment Instructions
Payment must be received prior to the meeting
Credit card
You can pay during your online registration using your credit card. Using this mode of payment you can guarantee that your fee has reached us prior to the conference and you will be listed as registered
Paypal
You can either use your Paypal account or click on the no account link to pay directly by credit or debit card
We do not store credit card details nor do we share customer details with any 3rd parties
If you wish to pay by cheque, purchase order or bank transfer, please contact sales [@] euroscicon.com
Cancellation Policy
Please note that we must receive payment in full before the meeting.
Delegates cancelling their registration at any point up to 2 months before the event will receive a full refund minus a £20.00 admin fee.
Delegates cancelling their registration at any point between 2 months and two weeks before the meeting will receive a 50% refund.
Delegates cancelling their registration two weeks before a meeting WILL NOT receive a refund.
Substitution of delegates can be made at any time through the registration system.
If you have not paid for a meeting that you have registered for and do not come (and do not provide 2 weeks notice of cancellation), you will be charged the full price of the meeting.